NHC.AMEXNational Healthcare CORP
Form 4: National Healthcare Corp Director Sandra Y. Trail Reports Stock Option Grant
Sentiment:
SEC Form 4
Director Sandra Y. Trail reports the grant of stock options in National Healthcare Corp.
Summary
- On May 9, 2024, Sandra Y. Trail, a director of National Healthcare Corp, reported the grant of 7,500 stock options.
- These options, with an exercise price of $96.03, were granted under the 2020 Omnibus Equity Incentive Plan.
- The options become exercisable on May 9, 2025, and expire on May 8, 2029.
- Trail also directly owns 3,614 shares of common stock.
Sentiment
Score: 6
Explanation: Neutral sentiment as it reports a routine stock option grant.
Positives
- The grant of stock options aligns the director's interests with those of the shareholders.
- The options provide an incentive for the director to contribute to the company's long-term success.
Future Outlook
NA
Industry Context
Stock option grants are a common practice in the healthcare industry to incentivize and retain key personnel.
Stakeholder Impact
- The stock option grant could potentially impact shareholders by diluting equity if the options are exercised.
Key Dates
| Date | Description |
|---|---|
| 05/05/2022 | Date exercisable for 2022 option grant |
| 05/04/2024 | Date exercisable for 2023 option grant |
| 05/09/2024 | Date of stock option grant and report filing |
| 05/09/2025 | Date exercisable for 2024 option grant |
| 05/04/2027 | Expiration date for 2022 option grant |
| 05/03/2028 | Expiration date for 2023 option grant |
| 05/08/2029 | Expiration date for 2024 option grant |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.